Relay Therapeutics
A Scientist at Relay Therapeutics integrates synthetic chemistry with cheminformatics to shape data-driven chemistry in a modern biotech environment. The role involves maintaining tools, designing synthetic workflows, and collaborating across disciplines to enhance drug discovery.
Headquarters
Cambridge, Massachusetts, United States
Company Size
51-200 employees
Founded
2016
Relay Therapeutics is a biotechnology company that puts protein motion at the heart of drug discovery, using computational modeling, machine learning, and experimental structural biology to reveal dynamic protein states and identify novel therapeutic opportunities. The company applies this platform to design and advance small‑molecule drug candidates, translating dynamic insights into lead programs and partnerships. Relay’s approach aims to expand the set of druggable targets and accelerate development of medicines across multiple disease areas.
Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Consensus Rating of "Moderate Buy" from Analysts
18 hours ago
Relay Therapeutics (RLAY) Soars 5.4%: Is Further Upside Left in the Stock?
1 day ago
Insider Sell: Thomas Catinazzo Sells Shares of Relay Therapeutics Inc (RLAY)
23 hours ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Relay Therapeutics.
22% below the average for this role
Zovegalisib Milestones To Shape The Future Of Relay Therapeutics
1 day ago
Senior Associate Scientist, R&D Chemistry
Regeneron Pharmaceuticals
Associate Principal Scientist - Cheminformatics
lifelancer
Research Senior Scientist, Cheminformatics
Takeda Pharmaceutical Company Limited
Senior / Principal Cheminformatics Scientist
Roche
Senior Scientist - Synthetic Chemist in Oligonucleotide Therapeutics
AstraZeneca
Senior Scientist I, Medicinal Chemistry
Pliant Therapeutics, Inc.